{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:57:02Z","timestamp":1792789022350,"version":"4.5.0"},"reference-count":59,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:00:00Z","timestamp":1728259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020955","name":"GSK funded this study","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020955","name":"GSK funded this study","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2024,12,31]]},"DOI":"10.1080\/21645515.2024.2406613","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T05:14:42Z","timestamp":1728278082000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":14,"title":["Inequalities in the risk and prevention of invasive meningococcal disease in the United States \u2013 A systematic literature review"],"prefix":"10.1080","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3521-8865","authenticated-orcid":false,"given":"Shahina","family":"Begum","sequence":"first","affiliation":[{"name":"GSK","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8193-999X","authenticated-orcid":false,"given":"Oscar","family":"Herrera-Restrepo","sequence":"additional","affiliation":[{"name":"GSK","place":["Philadelphia, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Rolland","sequence":"additional","affiliation":[{"name":"The Ark","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha","family":"Purushotham","sequence":"additional","affiliation":[{"name":"The Ark","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anar","family":"Andani","sequence":"additional","affiliation":[{"name":"GSK","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0204-451X","authenticated-orcid":false,"given":"Hiral","family":"Shah","sequence":"additional","affiliation":[{"name":"GSK","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5231-3389","authenticated-orcid":false,"given":"Zeki","family":"Kocaata","sequence":"additional","affiliation":[{"name":"GSK","place":["Wavre, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,10,7]]},"reference":[{"key":"e_1_3_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2016.03.041"},{"key":"e_1_3_8_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-13342-2"},{"key":"e_1_3_8_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-018-0213-2"},{"key":"e_1_3_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.05.079"},{"key":"e_1_3_8_6_1","unstructured":"Centers for disease control and prevention (CDC) meningococcal disease: surveillance. [accessed 2023 Apr 7]. https:\/\/www.cdc.gov\/meningococcal\/surveillance\/index.html."},{"key":"e_1_3_8_7_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6909a1"},{"key":"e_1_3_8_8_1","unstructured":"Advisory Committee on Immunization Practices (ACIP) ACIP Recommendations. 2023 Oct 25\u201326 [accessed 2023 Dec 11]. https:\/\/www.cdc.gov\/vaccines\/acip\/recommendations.html."},{"key":"e_1_3_8_9_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7234a3"},{"key":"e_1_3_8_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2022.2052048"},{"key":"e_1_3_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.03.071"},{"key":"e_1_3_8_12_1","unstructured":"World Health Organization (WHO). Social determinants of health. [accessed 2023 Apr 7]. https:\/\/www.who.int\/health-topics\/social-determinants-of-health#tab=tab_1."},{"key":"e_1_3_8_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/00333549141291S203"},{"key":"e_1_3_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2021.08.009"},{"key":"e_1_3_8_15_1","unstructured":"World Health Organization (WHO). Defeating meningitis by 2030: a global road map (2020). [accessed 2023 Sep 26]. https:\/\/www.who.int\/publications\/i\/item\/9789240026407."},{"key":"e_1_3_8_16_1","unstructured":"The cochrane collaboration cochrane handbook for systematic reviews of interventions. [accessed 2023 Apr 7]. https:\/\/training.cochrane.org\/handbook."},{"key":"e_1_3_8_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2700"},{"key":"e_1_3_8_18_1","unstructured":"Wells GA Shea B O\u2019Connell D Peterson J Welch V Losos M. The newcastle-ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000 [accessed 2023 Apr 7]. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"e_1_3_8_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-13-154"},{"key":"e_1_3_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.11.035"},{"key":"e_1_3_8_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy183"},{"key":"e_1_3_8_22_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.29303"},{"key":"e_1_3_8_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.8573"},{"key":"e_1_3_8_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu679"},{"key":"e_1_3_8_25_1","doi-asserted-by":"publisher","DOI":"10.1177\/0033354918781085"},{"key":"e_1_3_8_26_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2108.141932"},{"key":"e_1_3_8_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1632679"},{"key":"e_1_3_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.11.078"},{"key":"e_1_3_8_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac230"},{"key":"e_1_3_8_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix438"},{"key":"e_1_3_8_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit243"},{"key":"e_1_3_8_32_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-2130"},{"key":"e_1_3_8_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy548"},{"key":"e_1_3_8_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1682845"},{"key":"e_1_3_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2019.02.014"},{"key":"e_1_3_8_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000003455"},{"key":"e_1_3_8_37_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-09181-8"},{"key":"e_1_3_8_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2021.04.029"},{"key":"e_1_3_8_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.11.068"},{"key":"e_1_3_8_40_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7035a1"},{"key":"e_1_3_8_41_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0293070"},{"key":"e_1_3_8_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad607"},{"key":"e_1_3_8_43_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11020256"},{"key":"e_1_3_8_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-023-00793-2"},{"key":"e_1_3_8_45_1","doi-asserted-by":"publisher","DOI":"10.1177\/1090198117752786"},{"key":"e_1_3_8_46_1","unstructured":"Centers for disease control and prevention (CDC) vaccines for children (VFC) eligibility criteria. [accessed 2023 Oct 31]. https:\/\/www.cdc.gov\/vaccines\/programs\/vfc\/providers\/eligibility.html#SnippetTab."},{"key":"e_1_3_8_47_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6833a2"},{"key":"e_1_3_8_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad500.984"},{"key":"e_1_3_8_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000003033"},{"key":"e_1_3_8_50_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-12-338"},{"key":"e_1_3_8_51_1","unstructured":"Centers for disease control and prevention (CDC) recommended vaccines by age (special situations). 2023 [accessed 2023 Nov 1]. https:\/\/www.cdc.gov\/vaccines\/vpd\/vaccines-age.html."},{"key":"e_1_3_8_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-6773.2012.01449.x"},{"key":"e_1_3_8_53_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-19081-w"},{"key":"e_1_3_8_54_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-0344"},{"key":"e_1_3_8_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nurpra.2023.104793"},{"key":"e_1_3_8_56_1","unstructured":"Joint Committee on Vaccination and Immunisation (JCVI) Statement on HPV vaccination. 2018 [accessed 2024 Sep 2]. https:\/\/assets.publishing.service.gov.uk\/media\/5b4e0a34e5274a73119d7614\/JCVI_Statement_on_HPV_vaccination_2018.pdf."},{"key":"e_1_3_8_57_1","unstructured":"Government of Canada National Advisory Committee on Immunization (NACI). Guidelines for the economic evaluation of vaccination programs in Canada. [accessed 2024 Aug 27]. https:\/\/www.canada.ca\/en\/public-health\/programs\/guidelines-economic-evaluation-vaccine-programs-canada-stakeholder-consultation\/guidelines-document.html."},{"key":"e_1_3_8_58_1","unstructured":"Centers for Disease Control and Prevention (CDC)- Advisory Committee on Immunization Practices (ACIP). ACIP evidence to recommendations framework. [accessed 2024 Aug 27]. https:\/\/www.cdc.gov\/vaccines\/acip\/recs\/grade\/downloads\/acip-evidence-recs-framework.pdf."},{"key":"e_1_3_8_59_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12070773"},{"key":"e_1_3_8_60_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2023.2285366"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2024.2406613","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T13:13:59Z","timestamp":1744636439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2024.2406613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,7]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,31]]}},"alternative-id":["10.1080\/21645515.2024.2406613"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2024.2406613","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,7]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-05-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2406613"}}